News for Healthier Living

AACR: Clinical Trial Presentations Feature Advances Across Cancer Care

Early results for first-in-human and first-in-class therapies including an integrin inhibitor and a genetically engineered tumor infiltrating lymphocyte therapy ctDNA monitoring may be changing treatment options for patients Next-generation targeted therapies may allow de-escalation of treatment Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials during minisymposia at this week's American Association for Cancer Research (AACR) Annual Meeting 2026.

April 17, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026